| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.42 | 1e-13 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.4 | 1e-09 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.32 | 6e-08 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-08 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.24 | 1e-07 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-07 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.23 | 5e-07 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.23 | 5e-07 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-06 |